Serina Therapeutics
Serina Therapeutics is a clinical-stage pharmaceutical company based in Huntsville, Alabama, focused on developing novel therapeutics for neurological diseases, cancer, pain, and metabolic disorders. Founded in 2006, the company utilizes its proprietary polyoxazoline (POZ) polymer technology, which allows for the attachment of small molecules, proteins, peptides, and DNA to create new drug candidates with improved pharmacokinetic profiles. This technology aims to enhance the safety and efficacy of treatments. Serina's pipeline includes products targeting conditions such as Parkinson's disease, refractory epilepsy, post-operative pain management, and chemotherapy-induced nausea and vomiting. Through its innovative POZ platform, Serina Therapeutics seeks to address the limitations of traditional drug delivery methods and advance therapeutic solutions for challenging medical conditions.
AgeX Therapeutics is a biotechnology company dedicated to developing innovative therapeutics aimed at addressing human aging and degenerative diseases. Based in Alameda, California, the company focuses on harnessing proprietary technologies, such as telomerase-mediated cell immortality and induced Tissue Regeneration (iTR), to create treatments for age-related conditions. Its primary product pipeline includes two cell-based therapies: AGEX-BAT1, designed to treat age-related metabolic disorders like Type II diabetes, and AGEX-VASC1, which aims to restore vascular support in ischemic tissues. Additionally, AgeX is advancing AGEX-iTR1547, a drug-based formulation intended to enhance regenerative potential in aged tissues affected by degenerative diseases. The company also markets human embryonic stem cells and offers tools for genomic interpretation through the GeneCards Database Suite. AgeX Therapeutics collaborates with academic institutions, including a research program with the University of California, Irvine, focusing on neural stem cells for Huntington's disease and other neurological disorders. Founded in 2017, AgeX continues to explore novel solutions for aging-related challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.